Allarity Therapeutics, Inc. (ALLR) vs Palatin Technologies, Inc. (PTN)

Allarity Therapeutics, Inc. and Palatin Technologies, Inc. are both Biotechnology companies. Allarity Therapeutics, Inc. and Palatin Technologies, Inc. are of similar size ($17.5M and $17.3M). Allarity Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Palatin Technologies, Inc. trades at 2.4×. Allarity Therapeutics, Inc. has the higher net margin (0.00% vs −47.2%) and the higher return on invested capital (0.00% vs −942.3%). Across the 14 metrics below, Allarity Therapeutics, Inc. leads on 7 and Palatin Technologies, Inc. on 7.

Valuation

Metric ALLR PTN Biotechnology median
P/E n/m 2.43 7.88
P/S n/m 2.99 11.47
P/B 4.63 3.73 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.72 n/m 0.74
EV/Sales n/m 2.23 10.73
Earnings yield (75.73%) 41.20% (28.84%)
Free cash flow yield (85.91%) (37.93%) (23.03%)

Profitability

Metric ALLR PTN Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (49.26%) 0.00%
Net margin 0.00% (47.22%) 0.00%
Free cash flow margin 0.00% (113.25%) 0.00%
Return on equity (157.09%) (297.25%) (57.72%)
Return on assets (46.26%) (73.72%) (49.22%)
Return on invested capital 0.00% (942.30%) 0.00%

Growth

Metric ALLR PTN Biotechnology median
Revenue growth (TTM) — 86.46% 5.64%
EPS growth (last fiscal year) 95.02% 68.15% —
Revenue growth, 5-year CAGR — (40.52%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALLR PTN Biotechnology median
Debt to equity 0.40 0.00 0.00
Current ratio 1.11 5.04 4.73
Net debt to EBITDA 1.05 0.15 0.96

Dividend

Metric ALLR PTN Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ALLR PTN Biotechnology median
Market cap 17.34m 17.49m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack